우울장애의 신경생물학적 기전으로서 세포 내 신호전달계의 역할

참고문헌 (94)

1. Wong ML, "From monoamines to genomic targets: a paradigm shift for drug discovery in depression", Nat Rev Drug Discov, 3, pp.136~151 (2004)
2. Diazgranados N, "A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression", Arch Gen Psychiatry, 67, pp.793~802 (2010)
3. DiazGranados N, "Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder", J Clin Psychiatry, 71, pp.1605~1611 (2010)
4. Li N, "mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists", Science, 329, pp.959~964 (2010)
5. Autry AE, "NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses", Nature, 475, pp.91~95 (2011)[DOI]
6. Duman RS, "A neurotrophic model for stress-related mood disorders", Biol Psychiatry, 59, pp.1116~1127 (2006)
7. Manji HK, "Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics", Psychopharmacol Bull, 35, pp.5~49 (2001)
8. Manji HK, "The cellular neurobiology of depression", Nat Med, 7, pp.541~547 (2001)
9. Sheline YI, "Untreated depression and hippocampal volume loss", Am J Psychiatry, 160, pp.1516~1518 (2003)
10. Vermetten E, "Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder", Biol Psychiatry, 54, pp.693~702 (2003)
11. Czéh B, "Watanabe T, Frahm J, de Biurrun G, van Kampen M, et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine", Proc Natl Acad Sci U S A, 98, pp.12796~12801 (2001)
12. Madsen TM, "Increased neurogenesis in a model of electroconvulsive therapy", Biol Psychiatry, 47, pp.1043~1049 (2000)
13. Manev H, "Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro", Eur J Pharmacol, 411, pp.67~70 (2001)
14. Santarelli L, "Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants", Science, 301, pp.805~809 (2003)
15. Schmidt HD, "Future Antidepressant Targets: Neurotrophic Factors and Related Signaling Cascades", Drug Discov Today Ther Strateg, 5, pp.151~156 (2008)
16. David DJ, "Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety", depression, 2009, pp.62, 479~493
17. Bessa JM, "The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling", Mol Psychiatry, 14, pp.764~773 (2009)
18. Adayev T, "Transmembrane signaling in the brain by serotonin, a key regulator of physiology and emotion", Biosci Rep, 25, pp.363~385 (2005)
19. Zheng M, "Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling", Pharmacol Ther, 108, pp.257~268 (2005)
20. Aantaa R, "Molecular pharmacology of alpha 2-adrenoceptor subtypes", Ann Med, 27, pp.439~449 (1995)
21. Kamenetsky M, "Molecular details of cAMP generation in mammalian cells: a tale of two systems", J Mol Biol, 362, pp.623~639 (2006)
22. Dowlatshahi D, "Increased temporal cortex CREB concentrations and antidepressant treatment in major depression", Lancet, 352, pp.1754~1755 (1998)
23. Dowlatshahi D, "G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death", J Neurochem, 73, pp.1121~1126 (1999)
24. Cowburn RF, "Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims", Brain Res, 633, pp.297~304 (1994)
25. Manier DH, "Beta-adrenoceptorlinked protein kinase A (PKA) activity in human fibroblasts from normal subjects and from patients with major depression", Neuropsychopharmacology, 15, pp.555~561 (1996)
26. Manier DH, "Human fibroblasts as a relevant model to study signal transduction in affective disorders", J Affect Disord, 61, pp.51~58 (2000)
27. Perez J, "cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment", Eur J Pharmacol, 172, pp.305~316 (1989)
28. Nestler EJ, "Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex", J Neurochem, 53, pp.1644~1647 (1989)
29. Nibuya M, "Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus", J Neurosci, 16, pp.2365~2372 (1996)
30. Fujimaki K, "Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus", Neuropsychopharmacology, 22, pp.42~51 (2000)
31. Jeon SH, "Electroconvulsive shock increases the phosphorylation of cyclic AMP response element binding protein at Ser-133 in rat hippocampus but not in cerebellum", Neuropharmacology, 36, pp.411~414 (1997)
32. Thome J, "cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment", J Neurosci, 20, pp.4030~4036 (2000)
33. Deogracias R, "Expression of the neurotrophin receptor trkB is regulated by the cAMP", CREB pathway in neurons, 2004, pp.26, 470~480
34. Fukuchi M, "Transcriptional regulation of neuronal genes and its effect on neural functions: cumulative mRNA expression of PACAP and BDNF genes controlled by calcium and cAMP signals in neurons", J Pharmacol Sci, 98, pp.212~218 (2005)
35. McCauslin CS, "CAAT", enhancer-binding protein delta and cAMP-response element- binding protein mediate inducible expression of the nerve growth factor gene in the central nervous system, 2006, pp.281, 17681~17688
36. Chen AC, "Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect", Biol Psychiatry, 49, pp.753~762 (2001)
37. Newton SS, "Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressantlike effect", J Neurosci, 22, pp.10883~10890 (2002)
38. Pliakas AM, "Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element- binding protein expression in nucleus accumbens", J Neurosci, 21, pp.7397~7403 (2001)
39. Tanis KQ, "CREB binding and activity in brain: regional specificity and induction by electroconvulsive seizure", Biol Psychiatry, 63, pp.710~720 (2008)
40. Johnson GL, "Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases", Science, 298, pp.1911~1912 (2002)
41. Sweatt JD, "Mitogen-activated protein kinases in synaptic plasticity and memory", Curr Opin Neurobiol, 14, pp.311~317 (2004)
42. Wu GY, "Spaced stimuli stabilize MAPK pathway activation and its effects on dendritic morphology", Nat Neu rosci, 4, pp.151~158 (2001)
43. Roux PP, "ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions", Microbiol Mol Biol Rev, 68, pp.320~344 (2004)
44. Dwivedi Y, "ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf", Mol Psychiatry, 11, pp.86~98 (2006)
45. Dwivedi Y, "Reduced activation and expression of ERK1", 2 MAP kinase in the post-mortem brain of depressed suicide subjects, 2001, pp.77, 916~928
46. Karege F, "Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs", Brain Res Mol Brain Res, 136, pp.29~37 (2005)
47. Mercier G, "MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes", J Mol Neurosci, 24, pp.207~216 (2004)
48. Kodama M, "Electroconvulsive seizures increase the expression of MAP kinase phosphatases in limbic regions of rat brain", Neuropsychopharmacology, 30, pp.360~371 (2005)
49. Bhat RV, "Region-specific targets of p42", p44MAPK signaling in rat brain, 1998, pp.70, 558~571
50. Kang UG, "Activation of extracellular signal-regulated kinase signaling by chronic electroconvulsive shock in the rat frontal cortex", Psychiatry Res, 145, pp.75~78 (2006)
51. Gourley SL, "Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression", Biol Psychiatry, 63, pp.353~359 (2008)
52. Duman CH, "A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment", Biol Psychiatry, 61, pp.661~670 (2007)
53. Einat H, "The role of the extracellular signal-regulated kinase signaling pathway in mood modulation", J Neurosci, 23, pp.7311~7316 (2003)
54. Dwivedi Y, "Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects", Arch Gen Psychiatry, 60, pp.804~515 (2003)
55. Karege F, "Decreased serum brain-derived neurotrophic factor levels in major depressed patients", Psychiatry Res, 109, pp.143~148 (2002)
56. Shimizu E, "Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants", Biol Psychiatry, 54, pp.70~75 (2003)
57. Evans SJ, "Dysregulation of the fibroblast growth factor system in major depression", Proc Natl Acad Sci U S A, 101, pp.15506~15511 (2004)
58. Ueyama T, "Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain", Neurosci Res, 28, pp.103~110 (1997)
59. Heine VM, "Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk-1 protein expression", Eur J Neurosci, 21, pp.1304~1314 (2005)
60. Gonul AS, "Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients", Eur Arch Psychiatry Clin Neurosci, 255, pp.381~386 (2005)
61. Chen B, "Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication", Biol Psychiatry, 50, pp.260~265 (2001)
62. Aydemir O, "The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study", Prog Neuropsychopharmacol Biol Psychiatry, 29, pp.261~265 (2005)
63. Gervasoni N, "Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode", Neuropsychobiology, 51, pp.234~238 (2005)
64. Schmidt HD, "Peripheral BDNF produces antidepressant- like effects in cellular and behavioral models", Neuropsychopharmacology, 35, pp.2378~2391 (2010)
65. Shirayama Y, "Brainderived neurotrophic factor produces antidepressant effects in behavioral models of depression", J Neurosci, 22, pp.3251~3261 (2002)
66. Murphy LO, "MAPK signal specificity: the right place at the right time", Trends Biochem Sci, 31, pp.268~275 (2006)
67. Jeon SH, "MKP-1 induced in rat brain after electroconvulsive shock is independentof regulation of 42- and 44-kDa MAPK activity", Biochem BiophysRes Commun, 249, pp.692~696 (1998)
68. Duric V, "A negative regulator of MAP kinase causes depressive behavior", Nat Med, 16, pp.1328~1332 (2010)
69. Fayard E, "Protein kinase B", Akt at a glance, 2005, pp.118, 5675~5678
70. Beaulieu JM, "An Akt", beta-arrestin 2, Cell, pp.2005, 122[DOI]
71. Beaulieu JM, "Lithium antagonizes dopamine-dependent behaviors mediated by an AKT", glycogen synthase kinase 3 signaling cascade, 2004, pp.101, 5099~5104
72. Kang UG, "Activation of protein kinase B (Akt) signaling after electroconvulsive shock in the rat hippocampus", Prog Neuropsychopharmacol Biol Psychiatry, 28, pp.41~44 (2004)
73. Krishnan V, "AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli", Biol Psychiatry, 64, pp.691~700 (2008)
74. Polter A, "Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation", Biol Psychiatry, 65, pp.150~159 (2009)
75. Yu HS, "Activation of Akt signaling in rat brain by intracerebroventricular injection of ouabain: a rat model for mania", Prog Neuropsychopharmacol Biol Psychiatry, 34, pp.888~894 (2010)
76. Grimes CA, "The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling", Prog Neurobiol, 65, pp.391~426 (2001)
77. Klein PS, "A molecular mechanism for the effect of lithium on development", Proc Natl Acad Sci U S A, 93, pp.8455~8459 (1996)
78. Stambolic V, "Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells", Curr Biol, 6, pp.1664~1668 (1996)
79. Roh MS, "Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramine", Biol Psychiatry, 57, pp.278~286 (2005)
80. Li X, "In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain", Neuropsychopharmacology, 29, pp.1426~1431 (2004)
81. Madsen TM, "Chronic electroconvulsive seizure up-regulates beta-catenin expression in rat hippocampus: role in adult neurogenesis", Biol Psychiatry, 54, pp.1006~1014 (2003)
82. Roh MS, "Biphasic changes in the Ser-9 phosphorylation of glycogen synthase kinase-3beta after electroconvulsive shock in the rat brain", Prog Neuropsychopharmacol Biol Psychiatry, 27, pp.1~5 (2003)
83. Okamoto H, "Wnt2 expression and signaling is increased by different classes of antidepressant treatments", Biol Psychiatry, 68, pp.521~527 (2010)
84. Kaidanovich-Beilin O, "Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus", Biol Psychiatry, 55, pp.781~784 (2004)
85. Gould TD, "AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swimtest", Int J Neuropsychopharmacol, 7, pp.387~390 (2004)
86. Costa-Mattioli M, "Translational control of long-lasting synaptic plasticity and memory", Neuron, 61, pp.10~26 (2009)
87. Proud CG, "Signalling to translation: how signal transduction pathways control the protein synthetic machinery", Biochem J, 403, pp.217~234 (2007)
88. Lehman JA, "Molecular crosstalk between p70S6k and MAPK cell signaling pathways", Biochem Biophys Res Commun, 293, pp.463~469 (2002)
89. Roux PP, "RAS", ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation, 2007, pp.282, 14056~14064
90. Farber NB, "The NMDA receptor hypofunction model of psychosis", Ann N Y Acad Sci, 1003, pp.119~130 (2003)
91. Thomas DM, "MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity", Brain Res, 1050, pp.190~198 (2005)
92. Papp M, "Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression", Eur J Pharmacol, 263, pp.1~7 (1994)
93. Li N, "Glutamate Nmethyl- D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure", Biol Psychiatry, 69, pp.754~761 (2011)
94. Jernigan CS, "The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder", Prog Neuropsychopharmacol Biol Psychiatry, 35, pp.1774~1779 (2011)

관련 논문AI추천